Elevated levels of HER-2/neuand androgen receptor in clinically localized prostate cancer identifies metastatic potential
Author:
Publisher
Wiley
Subject
Urology,Oncology
Reference51 articles.
1. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer;Slamon;Science,1989
2. Monoclonal antibody therapy of human cancer: Taking the HER2 protooncogene to the clinic;Shepard;J Clin Immunol,1991
3. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses H ER2;Slamon;N Engl J Med,2001
4. Expression of p160erbB-3 and p185erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma;Myers;J Natl Cancer Inst,1994
5. Prognostic significance of HER-2/neu gene amplification status by fluorescence in situ hybridization of prostate carcinoma;Ross;Cancer,1997
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The association of HER-2 expression with clinicopathological characteristics and clinical outcomes in patients with localized prostate cancer after radical prostatectomy;2024-04-03
2. Regulating Androgen Receptor Function in Prostate Cancer: Exploring the Diversity of Post-Translational Modifications;Cells;2024-01-19
3. Frequencies of an Immunogenic HER-2/neu Epitope of CD8+ T Lymphocytes Predict Favorable Clinical Outcomes in Prostate Cancer;International Journal of Molecular Sciences;2023-03-22
4. Bispecific Antibodies in Targeted Cancer Immunotherapy;Handbook of Cancer and Immunology;2023
5. Bispecific Antibodies in Prostate Cancer Therapy: Current Status and Perspectives;Cancers;2021-02-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3